National Bank of Canada’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.49K Hold
405
﹤0.01% 2588
2025
Q4
$4.22K Hold
405
﹤0.01% 2464
2025
Q3
$3.64K Buy
405
+1
+0.2% +$9 ﹤0.01% 2506
2025
Q2
$5.24K Buy
+404
New +$6.07K ﹤0.01% 2482

Other funds holding RXST

National Bank of Canada's RXST Position: Q1 2026 in Review

National Bank of Canada held its RxSight (RXST) position steady in Q1 2026 at 405 shares worth $2.49K. The position accounts for ﹤0.01% of the portfolio, ranked #2588.

National Bank of Canada first reported a position in RXST in Q2 2025 and has held it in 4 quarters since. The position peaked at $5.24K in Q2 2025. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • National Bank of Canada held 405 shares of RxSight worth $2.49K as of Q1 2026.
  • National Bank of Canada left its RxSight share count unchanged in Q1 2026.
  • RxSight made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2588 holding.
  • National Bank of Canada first reported a position in RxSight in Q2 2025 and has held it in 4 quarters since.
  • National Bank of Canada's RxSight position peaked at $5.24K in Q2 2025.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.